跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,996 条关于
“TAK-928”
全部
5,996
临床试验
4,601
药物
903
机构
53
资讯
439
14小时前
Takeda to Present Late-Breaking Phase 3 Data for Claudin 18.2 ADC Arcotatug Tavatecan at ESMO 2026
5个月前
Innovent Advances First-in-Class IBI363 to Pivotal Trials for Immunotherapy-Resistant Lung Cancer
去年
Japanese Dengue Vaccine TAK-003 Approved for Use in Argentina
2个月前
92Bio Doses First Patient in Phase 1 Trial of NTB-928, a Next-Generation Bispecific T-Cell Engager for Platinum-Resistant Ovarian Cancer
2年前
Takeda's TAK-861 Shows Promising Results in Phase 2b Trial for Narcolepsy Type 1
2个月前
China Becomes First Globally to Approve Takeda's Novel Narcolepsy Drug TAK-861
去年
Takeda's Oral TYK2 Inhibitor TAK-279 Shows Promising Efficacy in Psoriasis Treatment
2年前
Takeda Advances TAK-861 to Phase III for Narcolepsy Type 1 Following Positive Phase IIb Results
去年
TAK-071 Shows Mixed Results in Parkinson's Disease Trial: Cognitive Benefits Observed Despite Missing Primary Endpoint
2年前
Takeda Presents New Data on TAK-861 Orexin Agonist for Narcolepsy at Sleep Europe 2024
第 1 页,共 44 页
上一页
下一页